Understanding the Side Effects of Mistletoe Injections

Mistletoe extract injections, such as those produced by ABNOBA GmbH, are increasingly being used as complementary therapy in oncology, particularly in Europe and growingly in India. Derived from the European mistletoe plant (Viscum album), these injections are believed to stimulate the immune system, improve quality of life, and potentially slow tumor growth. However, like any medical treatment, mistletoe therapy can present certain side effects.

Most side effects of mistletoe injections are mild and typically reflect the immune-activating nature of the therapy. Commonly reported symptoms include localized redness, swelling, or itching at the injection site. Some patients may also experience mild flu-like symptoms such as low-grade fever, chills, fatigue, or muscle aches. These are generally considered indicators of the immune system’s response and often subside with continued treatment.

In rare cases, stronger reactions can occur, including high fever, allergic reactions, or hypersensitivity. Such symptoms may require adjustment of dosage or a temporary pause in treatment. Importantly, mistletoe injections should always be administered under the supervision of a trained healthcare provider who can monitor patient response and make necessary adjustments.

ABNOBA GmbH, headquartered in Pforzheim, Germany, ensures pharmaceutical-grade quality and rigorous research standards in all of its mistletoe products. As the therapy continues to expand into markets like India through trusted partners, patient safety and scientific evidence remain at the forefront.

Before starting mistletoe therapy, patients are encouraged to discuss potential side effects and benefits with their oncologist or integrative medicine practitioner.